News
The Rise of the Psychedelics Sector
CPD Information: 1 Substantive Hour for Lawyers
External Speakers:
James Black - Canadian Securities Exchange, Vice President, Listings Development
Richard Carleton - CEO, Canadian Securities Exchange
Todd Shapiro - CEO, Red Light Holland
Maruf Raza - National Director of Public Companies, MNP
Doctors and others are administering substances, including psilocybin (i.e. magic mushrooms), ketamine, LSD and MDMA, in controlled settings to help patients with a variety of ailments. The international and Canadian domestic regulations associated with these substances are complex, with multiple organizations playing a role in regulating psychedelics.
Companies working with psychedelic-based drugs for medicinal purposes are now able to access capital and list on Canadian stock exchanges. With a number of companies having listed on Canadian stock exchanges, Canada has become an international go-to jurisdiction for the rise of the psychedelics sector.
Join our esteemed panel of experts as they provide an in-depth overview of the psychedelics sector, including the international and domestic regulatory framework, listing in Canada and where they see the industry within the next year.
Topics include:
James Black - Canadian Securities Exchange, Vice President, Listings Development
Richard Carleton - CEO, Canadian Securities Exchange
Todd Shapiro - CEO, Red Light Holland
Maruf Raza - National Director of Public Companies, MNP
ACCESS ARCHIVE
Mental health and well-being are now at the forefront of our daily lives. The search for alternative mental health treatments has led Western medicine to consider the efficacy of psychedelic substances.Doctors and others are administering substances, including psilocybin (i.e. magic mushrooms), ketamine, LSD and MDMA, in controlled settings to help patients with a variety of ailments. The international and Canadian domestic regulations associated with these substances are complex, with multiple organizations playing a role in regulating psychedelics.
Companies working with psychedelic-based drugs for medicinal purposes are now able to access capital and list on Canadian stock exchanges. With a number of companies having listed on Canadian stock exchanges, Canada has become an international go-to jurisdiction for the rise of the psychedelics sector.
Join our esteemed panel of experts as they provide an in-depth overview of the psychedelics sector, including the international and domestic regulatory framework, listing in Canada and where they see the industry within the next year.
Topics include:
- Potential for psychedelics gaining traction as an alternative form of treatment for mental illness and addiction
- The international and Canadian domestic regulations associated with psychedelics are complex, with multiple organizations playing a role in regulating psychedelics
For information on our Virtual Industry Updates, please contact: |
-
BioFull bio
With extensive experience in a broad range of corporate finance and commercial matters, Jeffrey offers clients a practical and business-minded approac...
-
BioFull bio
Sherri earns the trust of her clients by adeptly managing complex and time-sensitive corporate finance transactions and by providing relevant, busines...
